These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 28544457)

  • 21. Clinical value of Flash glucose monitoring in patients with type 1 diabetes treated with continuous subcutaneous insulin infusion.
    Moreno-Fernandez J; Pazos-Couselo M; González-Rodriguez M; Rozas P; Delgado M; Aguirre M; Garcia-Lopez JM
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Dec; 65(10):556-563. PubMed ID: 29907546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between metabolic control and self-monitoring of blood glucose in insulin-treated patients with diabetes mellitus.
    Soto González A; Quintela Fernández N; Pumar López A; Darias Garzón R; Rivas Fernández M; Barberá Comes G
    Endocrinol Nutr; 2015 May; 62(5):233-9. PubMed ID: 25814324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Translating glycated hemoglobin A1c into time spent in glucose target range: A multicenter study.
    Petersson J; Åkesson K; Sundberg F; Särnblad S
    Pediatr Diabetes; 2019 May; 20(3):339-344. PubMed ID: 30652407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Pratley RE; Kanapka LG; Rickels MR; Ahmann A; Aleppo G; Beck R; Bhargava A; Bode BW; Carlson A; Chaytor NS; Fox DS; Goland R; Hirsch IB; Kruger D; Kudva YC; Levy C; McGill JB; Peters A; Philipson L; Philis-Tsimikas A; Pop-Busui R; Shah VN; Thompson M; Vendrame F; Verdejo A; Weinstock RS; Young L; Miller KM;
    JAMA; 2020 Jun; 323(23):2397-2406. PubMed ID: 32543682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program.
    Billings LK; Parkin CG; Price D
    Diabetes Technol Ther; 2018 Aug; 20(8):561-565. PubMed ID: 30044123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
    Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D;
    JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensor and software use for the glycaemic management of insulin-treated type 1 and type 2 diabetes patients.
    Ajjan RA; Abougila K; Bellary S; Collier A; Franke B; Jude EB; Rayman G; Robinson A; Singh BM
    Diab Vasc Dis Res; 2016 May; 13(3):211-9. PubMed ID: 27000105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flash glucose monitoring and automated bolus calculation in type 1 diabetes treated with multiple daily insulin injections: a 26 week randomised, controlled, multicentre trial.
    Secher AL; Pedersen-Bjergaard U; Svendsen OL; Gade-Rasmussen B; Almdal T; Raimond L; Vistisen D; Nørgaard K
    Diabetologia; 2021 Dec; 64(12):2713-2724. PubMed ID: 34495375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.
    Lind M; Polonsky W; Hirsch IB; Heise T; Bolinder J; Dahlqvist S; Schwarz E; Ólafsdóttir AF; Frid A; Wedel H; Ahlén E; Nyström T; Hellman J
    JAMA; 2017 Jan; 317(4):379-387. PubMed ID: 28118454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes.
    Ziegler R; Heidtmann B; Hilgard D; Hofer S; Rosenbauer J; Holl R;
    Pediatr Diabetes; 2011 Feb; 12(1):11-7. PubMed ID: 20337978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Young patients with type 1 diabetes poorly controlled and poorly compliant with self-monitoring of blood glucose: can technology help? Results of the i-NewTrend randomized clinical trial.
    Di Bartolo P; Nicolucci A; Cherubini V; Iafusco D; Scardapane M; Rossi MC
    Acta Diabetol; 2017 Apr; 54(4):393-402. PubMed ID: 28138788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment intensification without improved HbA1c levels in children and adolescents with Type 1 diabetes mellitus.
    Sildorf SM; Hertel NT; Thomsen J; Fredheim S; Hastrup H; Pipper C; Hertz B; Svensson J;
    Diabet Med; 2016 Apr; 33(4):515-22. PubMed ID: 26333180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the relationship between glycated hemoglobin A1c and mean glucose levels derived from the professional continuous flash glucose monitoring system.
    Yamada M; Okada S; Oda H; Nakajima Y; C Bastie C; Kasai Y; Osaki A; Shimoda Y; Shibusawa R; Uehara R; Saito T; Ozawa A; Yamada E
    Endocr J; 2020 May; 67(5):531-536. PubMed ID: 32023560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paediatric estimated average glucose in children with Type 1 diabetes.
    O'Riordan SM; Danne T; Hanas R; Peters CJ; Hindmarsh P
    Diabet Med; 2014 Jan; 31(1):36-9. PubMed ID: 23869869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial.
    Oskarsson P; Antuna R; Geelhoed-Duijvestijn P; Krӧger J; Weitgasser R; Bolinder J
    Diabetologia; 2018 Mar; 61(3):539-550. PubMed ID: 29273897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pragmatic real-life study of flash glucose monitoring versus self-monitoring of blood glucose.
    Greve SV; Stilgren L
    Dan Med J; 2020 Jun; 67(6):. PubMed ID: 32741434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Association Between HbA
    Seyed Ahmadi S; Westman K; Pivodic A; Ólafsdóttir AF; Dahlqvist S; Hirsch IB; Hellman J; Ekelund M; Heise T; Polonsky W; Wijkman M; Schwarcz E; Lind M
    Diabetes Care; 2020 Sep; 43(9):2017-2024. PubMed ID: 32641374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of self-monitoring of blood glucose in patients with Type 1 diabetes: a multi-centre study in Brazil.
    Gomes MB; Tannus LR; Cobas RA; Matheus AS; Dualib P; Zucatti AT; Cani C; Guedes AD; Santos FM; Sepulveda J; Tolentino M; Façanha MC; Faria AC; Lavigne S; Montenegro AP; Rodacki M; de Fatima Guedes M; Szundy R; Cordeiro MM; Santos PT; Negrato CA;
    Diabet Med; 2013 Oct; 30(10):1255-62. PubMed ID: 23721292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring the inter-subject variability in the relationship between glucose monitoring metrics and glycated hemoglobin for pediatric patients with type 1 diabetes.
    Bosoni P; Calcaterra V; Tibollo V; Malovini A; Zuccotti G; Mameli C; Sacchi L; Bellazzi R; Larizza C
    J Pediatr Endocrinol Metab; 2021 May; 34(5):619-625. PubMed ID: 33823102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.